Novartis Axing 320 Jobs at Irish Manufacturing Plant
Novartis Axing 320 Jobs at Irish Manufacturing Plant
GALWAY, IRELAND--November 4, 2019--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--Swiss pharmaceutical company Novartis International AG (NYSE:NVS) (Basel, Switzerland) is axing more than half of the employees at its Irish active pharmaceutical ingredient (API) manufacturing operation at the Ringaskiddy campus in Cork by mid-2022.
Within this article: Details job cuts, impact, related activities in Europe
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- Janssen Injecting $176 Million into Irish Biomedicines Plant
- Samsung Biologics Constructing ADC Plant in South Korea
- Data Center Activity Propels Virginia to $12.7 Billion of Projects Under Co...
- Pharma Company Zoetis Signs PPA with Scout Clean Energy to Support Growing ...
- China's Rongsheng Petrochemical Ups Role in Polyester Chips